Inactive Instrument

Insiders Sevion Therapeutics Inc OTC Bulletin Board

Equities

US81834Q1040

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Apr. 11	North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	DJ
Mar. 13	Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eloxx Pharmaceuticals, Inc. Announces Resignation of Tomer Kariv from the Board	Dec. 28	CI
Eloxx Pharmaceuticals, Inc. Announces Resignation of Vijay Modur as Head of Research and Development	23-09-15	CI
Eloxx Pharmaceuticals, Inc. Announces Committee Changes	22-07-05	CI
Eloxx Pharmaceuticals Announces Changes to Board of Directors	22-07-05	CI
Eloxx Pharmaceuticals, Inc. Appoints Ali Hariri as Chief Medical Officer	21-11-09	CI
Eloxx Pharmaceuticals, Inc. Appoints Ali Hariri as Chief Medical Officer	21-09-08	CI
Eloxx Pharmaceuticals, Inc. Appoints Daniel Geffken as Principal Accounting Officer	21-08-20	CI
Gary Rakers to Resign as Executive Director, Finance & Accounting, Corporate Conroller and Treasurer of Eloxx Pharmaceuticals, Inc, Effective July 30, 2021	21-07-16	CI
Eloxx Pharmaceuticals, Inc. Announces the departure of Neil Belloff as Chief Operating Officer and General Counsel, Effective August 25, 2021	21-07-06	CI
Eloxx Pharmaceuticals, Inc. Announces Executive Changes	21-04-01	CI
Eloxx Pharmaceuticals, Inc. Announces Change of CEO	21-04-01	CI
Eloxx Pharmaceuticals, Inc. Appoints Daniel Geffken as Interim Chief Financial Officer	21-04-01	CI
Eloxx Pharmaceuticals, Inc. Announces Board Changes	21-03-26	CI
Eloxx Pharmaceuticals, Inc. Announces Resignation of Stephen Macdonald as Vice President, Finance and Accounting, and Treasurer (Principal Financial and Accounting Officer) Effective March 26, 2021	21-03-12	CI
Eloxx Pharmaceuticals, Inc. Announces Appointment of Eitan Kerem as Senior Consultant	20-09-14	CI
Eloxx Pharmaceuticals, Inc. Announces Executive Changes; Announces Organizational Re-Alignment	20-02-26	CI
Eloxx Pharmaceuticals, Inc. Hires Susan Schneider as Senior Vice President Ophthalmology	19-03-08	CI
Pedro Huertas Intention to Resign as Chief Medical Officer of Eloxx Pharmaceuticals, Inc	18-08-03	CI
Eloxx Pharmaceuticals, Inc. Announces Executive Appointments	18-06-25	CI
Eloxx Pharmaceuticals, Inc. Appoints Neil Belloff as Executive Vice President, General Counsel and Corporate Secretary	18-06-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Sevion Therapeutics Inc OTC Bulletin Board

Equities

US81834Q1040

Insiders

Filters